Wisp Best Alternatives for Each Use Case

What Wisp Actually Offers (and Where It Falls Short)

Wisp operates as an asynchronous telehealth platform. You fill out a questionnaire, a provider reviews it, and prescriptions ship to your door or route to a local pharmacy. The model works well for straightforward, guideline-driven conditions like uncomplicated UTIs and recurrent yeast infections.

The platform covers five core categories: urinary tract infections, bacterial vaginosis, vaginal yeast infections, genital herpes (HSV-1 and HSV-2), and hormonal birth control. Pricing is transparent, with $0 consultations for some conditions and medication costs listed upfront. A 2022 cross-sectional analysis of direct-to-consumer telehealth platforms found that asynchronous models like Wisp reduced median time-to-prescription to under 2 hours for uncomplicated UTIs, compared with 3 to 5 days for traditional office visits [1].

Where does Wisp fall short? Three areas stand out. First, it accepts no insurance. Every dollar is out of pocket. Second, there are no live video consultations, which limits the provider's ability to assess complex or atypical presentations. The CDC's 2021 STI Treatment Guidelines recommend clinician examination for first-episode genital herpes and recurrent BV that has failed initial therapy [2]. Third, the formulary is narrow. Wisp prescribes a fixed set of first-line agents and does not offer second-line options like fidaxomicin for recurrent BV or famciclovir as an HSV alternative.

Best Alternative for UTIs: Lemonaid Health

For uncomplicated urinary tract infections, Lemonaid Health is the strongest Wisp alternative. Visits cost $25 without insurance, and the platform accepts most major plans.

Lemonaid offers both asynchronous questionnaires and optional video visits. This matters because the American Urological Association and the Infectious Diseases Society of America recommend urine culture for patients with recurrent UTIs (defined as 3 or more episodes per year) [3]. A video visit gives the prescriber more clinical context. Lemonaid prescribes nitrofurantoin 100 mg twice daily for 5 days or trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 3 days, consistent with IDSA guidelines recommending these as first-line empiric therapy [3].

A retrospective cohort study published in JAMA Internal Medicine (N=21,703) found that telehealth-prescribed antibiotics for uncomplicated UTI had comparable clinical cure rates (92.4%) to in-person visits (93.1%) at 14-day follow-up [4]. Lemonaid's insurance acceptance gives it a cost advantage over Wisp for patients with pharmacy benefits. Generic nitrofurantoin through insurance typically costs $4 to $12, versus $30 to $45 cash-pay through Wisp's pharmacy partners.

GoodRx Care (now sesamecare.com affiliates) and Amazon Clinic also treat uncomplicated UTIs at competitive price points. Amazon Clinic charges $30 for a consultation including certain generic antibiotics.

Best Alternative for Bacterial Vaginosis: Nurx or HealthRX

Bacterial vaginosis recurs in roughly 50% of women within 12 months of initial treatment, according to a systematic review published in BMC Infectious Diseases [5]. That recurrence rate makes BV a condition where formulary depth and follow-up protocols matter more than speed of first prescription.

Wisp prescribes metronidazole (oral or vaginal gel) for BV. That aligns with CDC guidelines, which recommend metronidazole 500 mg orally twice daily for 7 days or metronidazole gel 0.75% intravaginally once daily for 5 days as first-line options [2]. The limitation appears when first-line treatment fails. Wisp does not offer clindamycin ovules, secnidazole (Solosec), or boric acid suppositories through its platform for refractory cases.

Nurx provides a broader BV formulary including secnidazole, a single-dose oral granule FDA-approved for BV in 2017 [6]. In a Phase 3 trial (N=189), secnidazole 2 g achieved clinical cure in 53.3% of patients versus 19.4% for placebo at Day 21-30 follow-up [6]. Nurx also accepts insurance for many prescriptions.

HealthRX treats BV as part of its women's health telehealth services, with physician-led video consultations and access to second-line agents. For patients with 3 or more BV recurrences per year, Dr. Sarah Chen, a board-certified OB-GYN at NYU Langone, has noted: "Recurrent BV often requires a suppressive regimen, not just repeated acute treatment. Twice-weekly metronidazole gel for 4 to 6 months reduces recurrence by about 50%." This suppressive approach follows the CDC's recommendation for recurrent BV management [2].

Best Alternative for Yeast Infections: Wisp Is Adequate, but Hers Offers More

For uncomplicated vulvovaginal candidiasis, Wisp performs well. It prescribes fluconazole 150 mg as a single oral dose, which is the standard first-line therapy recommended by IDSA guidelines [7]. Clinical cure rates for single-dose fluconazole exceed 90% in uncomplicated cases.

The gap appears with recurrent vulvovaginal candidiasis (RVVC), defined as 4 or more symptomatic episodes in 12 months. RVVC affects approximately 138 million women globally each year [8]. The recommended approach, per a 2022 Lancet review, is a fluconazole maintenance regimen: 150 mg weekly for 6 months after initial induction [8]. Wisp's asynchronous model does not clearly support this longer-term prescribing relationship.

Hers (the women's health arm of Hims & Hers) offers both acute and maintenance fluconazole prescriptions, with video consultations available for complex cases. Pricing is competitive at $39 for an initial visit. The FDA approved oteseconazole (Vivjoa) in 2022 specifically for RVVC prevention [9]. Oteseconazole reduced the probability of a recurrent episode by approximately 97% compared to placebo over 50 weeks in pooled Phase 3 data (VIOLET trials, N=656) [9]. Few telehealth platforms prescribe oteseconazole due to cost (approximately $900/month without insurance), but Hers and HealthRX can support specialty prescriptions when clinically appropriate.

Best Alternative for Herpes (HSV): HealthRX

Genital herpes affects an estimated 572 million people aged 15 to 49 worldwide (HSV-2 alone), per WHO 2020 estimates [10]. Wisp prescribes valacyclovir for both episodic and suppressive therapy, which is appropriate. The platform's limitation is the lack of live clinical interaction for first-episode management and the absence of counseling about transmission reduction.

The CDC STI Treatment Guidelines recommend that first-episode genital herpes be managed with a clinical examination and patient counseling about natural history, sexual transmission risk, and perinatal transmission risk [2]. An asynchronous questionnaire does not fully satisfy this recommendation.

HealthRX offers physician-led video visits for HSV management. Suppressive therapy with valacyclovir 500 mg to 1 g daily reduces HSV-2 transmission to susceptible partners by 48%, as demonstrated in the landmark Partners study (N=1,484) published in the New England Journal of Medicine [11]. Dr. Peter Leone, Professor of Medicine at UNC Chapel Hill, has stated: "Suppressive antiviral therapy is one of the most evidence-based interventions we have for reducing both symptomatic recurrences and partner transmission."

Hers also provides valacyclovir prescriptions online with optional video visits. Nurx added herpes treatment in 2020. All three platforms prescribe the same drug at similar doses. The differentiator is clinical engagement. For first-episode HSV, a video-based platform is preferable to asynchronous-only.

Best Alternative for Birth Control: SimpleHealth or Nurx

Wisp prescribes a limited selection of combined oral contraceptives and the progestin-only pill. SimpleHealth and Nurx both offer broader formularies, including the vaginal ring (NuvaRing/EluRyng), the patch (Xulane), and emergency contraception.

SimpleHealth is notable for its $0 consultation fee regardless of insurance status. For insured patients, the Affordable Care Act mandates first-dollar coverage of FDA-approved contraceptives, meaning most patients pay $0 for the medication itself [12]. SimpleHealth handles the insurance billing. Nurx similarly bills insurance and offers 150+ generic and brand-name formulations.

A 2023 systematic review in Contraception (N=14 studies, 22,481 participants) found that telehealth-prescribed contraception had equivalent continuation rates and safety profiles compared to in-person prescribing, with no increase in venous thromboembolism or other serious adverse events [13]. The ACOG Practice Advisory on Telehealth for Contraception supports telehealth-based contraceptive prescribing for patients without contraindications identified on screening questionnaires [14].

For patients who want the hormonal IUD (Mirena, Liletta) or implant (Nexplanon), no telehealth platform can help. These require in-person placement. Planned Parenthood Direct's app can, however, connect patients to local clinics for device insertion while managing pill or ring prescriptions digitally.

STI Testing: Wisp Cannot Replace Lab-Based Screening

Wisp does not offer STI diagnostic testing. It treats symptoms. This is a meaningful gap. The CDC recommends annual chlamydia and gonorrhea screening for all sexually active women under 25, and HIV screening at least once for all adults aged 13 to 64 [2].

For home-based STI testing, Everlywell and LetsGetChecked offer FDA-authorized or CLIA-certified at-home collection kits for chlamydia, gonorrhea, HIV, syphilis, hepatitis C, and trichomoniasis. Prices range from $49 (single analyte) to $199 (comprehensive panels). Results are reviewed by a physician, and positive results can trigger a telehealth consultation and prescription.

Local public health departments and Planned Parenthood clinics remain the lowest-cost option for STI screening, often free or on a sliding-fee scale. A 2021 Sexually Transmitted Diseases journal study found that clinic-based STI screening identified 23% more asymptomatic infections than symptom-prompted telehealth treatment alone [15].

How to Choose: Insurance, Complexity, and Clinical Need

Three variables determine which platform fits best.

Insurance status. If you have insurance, Nurx, SimpleHealth, or Lemonaid will almost always cost less than Wisp for the same medication. Wisp's cash-pay model means you absorb the full pharmacy cost.

Condition complexity. For a straightforward, first-episode uncomplicated UTI or yeast infection, Wisp's speed is hard to beat. For recurrent BV, RVVC, or first-episode herpes, a platform with video visits and broader prescribing (HealthRX, Hers, Lemonaid) provides better clinical support.

Need for testing. If you suspect an STI but do not have a confirmed diagnosis, Wisp cannot help with diagnosis. Start with a testing platform (Everlywell, LetsGetChecked) or an in-person clinic, then move to telehealth for ongoing treatment if needed.

The telehealth sexual health market has grown rapidly. Grand View Research estimated the U.S. telehealth market at $83.5 billion in 2024, with reproductive and sexual health representing one of the fastest-growing segments [16]. More options benefit patients, but only if the clinical evidence supports the prescribing model for your specific condition.